Therefore, further larger studies are certainly needed to further corroborate these data in other independent cohorts of individuals with and without T2DM, and for better elucidating the complex biological mechanisms underpinning the association between plasma LRG1 levels and specific plasma ceramides, especially those with long acyl-chain lengths and unsaturated compounds. The gene discussed is LRG1; the disease is type 2 diabetes mellitus.